Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 58 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 12/20/21
Due: 12/20/22
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 10/01/25
Due: 10/01/26
Phase: N/A
Priority: Normal
Start: 12/02/24
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 08/13/18
End: 12/01/19
Due: 12/01/20
Phase: N/A
Priority: Normal
Start: 01/03/22
End: 01/03/24
Due: 01/03/25
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 09/01/25
Due: 09/01/26
Phase: N/A
Priority: Normal
Start: 09/01/18
End: 05/01/21
Due: 05/01/22
Phase: N/A
Priority: Normal
Start: 04/29/21
End: 11/29/22
Due: 11/29/23
Characteristics and Limitations of Intraoperative OCT Supported Membrane Peeling in Macular Diseases
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 01/03/22
End: 01/03/24
Due: 01/03/25
Phase: N/A
Priority: Normal
Start: 10/31/20
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 11/19/19
End: 11/01/23
Due: 11/01/24
Phase: N/A
Priority: Normal
Start: 10/15/20
End: 03/31/21
Due: 03/31/22
Phase: N/A
Priority: Normal
Start: 11/16/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 02/28/15
Due: 02/28/16
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 11/30/12
Due: 11/30/13
Retrospective Evaluation of Risk Factors for Lower Outcomes After Vitrectomy With ILM Flap Technique
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 05/01/21
Due: 05/01/22
Phase: N/A
Priority: Normal
Start: 04/17/18
End: 01/01/20
Due: 01/01/21
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 05/12/21
End: 08/27/21
Due: 08/27/22
Phase: N/A
Priority: Normal
Start: 10/10/14
End: 02/01/17
Due: 02/01/18
Phase: N/A
Priority: Normal
Start: 05/12/21
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 08/01/17
End: 08/01/24
Due: 08/01/25